Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis

NCT02182700 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: salbutamol sulfate + ipratropium bromide

Sponsor

Boehringer Ingelheim